MQR Share Price Performance
zł3.19
-3.77 (-54.17%)
Price zł3.19
Share Pricen/a
MultiQure S.A. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
MQR Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
No trending discussion available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
MultiQure S.A. Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Sep 30, 2026
- -0.74
- 0%
- 0%
- -100.3%
About MQR
- Founded
- 2010
- Employees
- 7
- CEO
- WebsiteView website
MultiQure S.A., a biopharmaceutical company, engages in the research and development of biological drugs and medical devices for therapeutic use. Its therapeutic portfolio in the field of immuno-oncology includes PB003G, which targets the GARP-TGFß1 complex; PB004, an anticancer drug based on an anti-ROR1 antibody; and PB003A, a therapy that targets the aVß8 integrin. The company was formerly known as Pure Biologics S.A. and changed its name to MultiQure S.A. in August 2026. The company was founded in 2010 and is based in Wroclaw, Poland.
